Citron CEO: Gap Is 'Comletely Irrelevant,' Stock Headed Below $20

TL;DR

Citron CEO discusses stock predictions for Valeant, Monster, Mobileye, and Gap.

Transcript

let's talk about some of the positions that you've taken you were short valiant you have covered that position now was it because of the restatement the 58 million dollars that changed your view no I covered valiant beforehand there's a lot that is uncertain with the company and at these prices right here I'd rather be in situations that I have mor... Read More

Key Insights

• Citron CEO Andrew Left discusses his decision to cover his short position on Valeant, citing uncertainty and a lack of risk-reward balance.
• Andrew Left believes that Monster's growth may be limited due to its mature market position, despite its strong execution and recent supply chain acquisition.
• Left expresses skepticism about Monster's potential success in China, highlighting challenges related to licensing, costs, and brand establishment.
• Citron's report is critical of Monster's China strategy, despite analyst optimism, suggesting that Monster's management has not prioritized entry into the Chinese market.
• Andrew Left maintains a short position on Mobileye, questioning the company's commitment to research and development and its management's stock selling practices.
• Left describes Gap as an irrelevant retailer, citing declining consumer interest and store closures as reasons for his short position.
• The analysis suggests that Gap's stock could fall below $20 due to its diminishing relevance and financial challenges.
• Citron Research founder Andrew Left provides insights into his investment strategies and stock price predictions during an interview on Bloomberg Markets.

Questions & Answers

Q: Why did Andrew Left cover his short position on Valeant?

Andrew Left covered his short position on Valeant because he found the company to be uncertain and lacking a favorable risk-reward balance. He believes that the restatement of financials is the start of a longer process, and he prefers to invest in situations where he has more certainty.

Q: What is Andrew Left's view on Monster's growth potential?

Andrew Left believes that Monster's growth potential is limited due to its mature market position. He acknowledges the company's strong execution but suggests that its recent supply chain acquisition indicates a shift towards cost management rather than growth. He argues that Monster should be valued like other beverage companies with similar competition.

Q: Why is Andrew Left skeptical about Monster's success in China?

Andrew Left is skeptical about Monster's success in China due to several challenges. He highlights the need for licensing, the high costs of selling in China, and the difficulty of establishing Monster's brand in the market. He also points out that Monster's management has not prioritized entry into China, which he sees as a significant obstacle.

Q: What is Citron's report's stance on Monster's China strategy?

Citron's report is critical of Monster's China strategy, despite the optimism of some analysts. The report suggests that Monster's management has not prioritized entry into the Chinese market, and it questions the feasibility of Monster's success in China due to licensing, cost, and brand establishment challenges.

Q: What are Andrew Left's concerns about Mobileye?

Andrew Left's concerns about Mobileye revolve around the company's commitment to research and development. He questions the management's decision to sell stock while not dedicating enough resources to R&D. He believes that Mobileye's management has not been transparent enough, which makes it a comfortable short position.

Q: Why does Andrew Left consider Gap an irrelevant retailer?

Andrew Left considers Gap an irrelevant retailer because of declining consumer interest and the closure of stores. He cites surveys showing that Gap is no longer a preferred shopping destination, and he believes that the company's financial challenges will lead to a further decline in stock value.

Q: What is Andrew Left's prediction for Gap's stock price?

Andrew Left predicts that Gap's stock price could fall below $20 within the next six months. He bases this prediction on Gap's diminishing relevance in the retail market, store closures, and the overall decline in consumer interest, which he believes will negatively impact the company's financial performance.

Q: What insights does Andrew Left share about his investment strategies?

Andrew Left shares insights into his investment strategies by discussing his decisions to cover or maintain short positions on various stocks. He emphasizes the importance of certainty and risk-reward balance in his investments. He also highlights the significance of market maturity and competition in evaluating a company's growth potential.

Summary & Key Takeaways

• Andrew Left of Citron Research discusses his investment strategies and stock predictions for companies like Valeant, Monster, Mobileye, and Gap. He explains his decision to cover his short position on Valeant due to uncertainty and lack of risk-reward balance. He remains skeptical about Monster's growth potential in China.

• Left argues that Monster's market position is mature, making its growth prospects limited. He questions Monster's potential success in China, citing challenges such as licensing, costs, and brand establishment. Despite analyst optimism, he believes Monster's management has not prioritized entry into the Chinese market.

• Left maintains a short position on Mobileye, questioning the company's commitment to research and development. He also describes Gap as an irrelevant retailer, citing declining consumer interest and store closures as reasons for his short position. He predicts Gap's stock could fall below $20.